Advisers to the Food and Drug Administration on Wednesday endorsed COVID-19 vaccines for use in kids ages 6 months to 4 years, meaning the youngest Americans should be eligible for the shots by next week.
The advisory committee blessed the Pfizer shots for ages 6 months to 4 years in a 21-0 vote, and the Moderna shots for ages 6 months to 5 years by the same margin. Advisers said families deserve the chance to protect their children from severe disease as fast-moving variants blanket the country.
“It’s a matter of choice,” said Dr. Wayne Marasco, an adviser and professor of medicine at Harvard Medical School.